HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology164 papers

Steroid-induced diabetes

Last edited: 4/15/2026

Overview

Steroid-induced diabetes refers to the development of hyperglycemia or frank diabetes mellitus as a complication of steroid use, typically due to the catabolic effects of glucocorticoids impairing insulin sensitivity and glucose metabolism. 1

Diagnosis

  • Monitor blood sugar levels, especially in patients on long-term systemic steroid therapy.
  • Consider baseline and periodic HbA1c measurements to assess glycemic control.
  • Evaluate for symptoms of hyperglycemia such as polyuria, polydipsia, and unexplained weight loss.
  • Assess for risk factors including prior history of diabetes, obesity, and other metabolic disorders. 1

    • Management

  • Initiate or adjust antidiabetic medications as needed, such as metformin, insulin, or other glucose-lowering agents based on glycemic control.
  • Regularly monitor and adjust steroid dosage in consultation with endocrinology to minimize glucose elevation.
  • Implement lifestyle modifications including diet and exercise to support glycemic management.
  • Closely monitor for other steroid-related complications and manage accordingly. 1

    • Special Populations

  • Pregnancy: Increased vigilance in monitoring glucose levels due to heightened metabolic demands and potential exacerbation of steroid effects. 1
  • Comorbidities: Patients with pre-existing diabetes or other metabolic conditions require heightened monitoring and individualized management plans. 1

    • Key Recommendations

  • Assess and monitor blood sugar levels before initiating long-term systemic steroid therapy, especially in patients with risk factors for diabetes. (Evidence: Moderate) 1
  • Consider baseline HbA1c and regular follow-up HbA1c measurements in patients on prolonged steroid treatment to detect early changes in glycemic control. (Evidence: Moderate) 1
  • Collaborate with endocrinology for management adjustments in patients developing steroid-induced hyperglycemia requiring antidiabetic therapy. (Evidence: Expert opinion) 1

    • References

    1 Renfro L, Snow JS. Ocular effects of topical and systemic steroids. Dermatologic clinics 1992. link

    Original source

    1. [1]
      Ocular effects of topical and systemic steroids. — Renfro L, Snow JS Dermatologic clinics (1992)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG